ALL-440: Promising Safety and Efficacy Results from an Ongoing Phase 1/2 Study of Pembrolizumab in Combination with Blinatumomab in Patients (pts) with Relapsed or Refractory (R/R) Acute Lymphoblastic Leukemia (ALL)
Year: 2021
Type: conference-abstract
Authors: Karamjeet S. Sandhu, Quy Huynh-Tran, Elise Elise Cooper, Jianying zhang, Joycelynne Palmer, Ni-Chun Tsai, Sandra Thomas, Marjorie Robbins, Ahmed Aribi, Amandeep Salhotra, Mathew Mei, Ji-Lian Cai, Ricardo Spielberger, Paul Koller, Ibrahim Aldoss, Anthony Stein, Guido Marcucci, L. Elizabeth Budde
Institutions: City Of Hope National Medical Center, Kaiser Permanente
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3197119660